CClinicalTrials.gg
CompletedNCT05416671Updated Jun 13, 2022

The Effect of Guided Narrative Technique on Child Post-traumatic Stress Symptoms Related to Teachers' Improper Criticism

An interventional study of guided narrative technique-writing in Posttraumatic Stress Symptoms, sponsored by Peking University. Completed at 1 site in China. Open to participants aged 7 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-13.

Sponsored by Peking University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled May 2020, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
7 Years to 13 Years
Sex
All
01

Study summary

Teachers' improper criticism may lead to posttraumatic stress symptoms (PTSS) in children. This cluster randomized controlled trial examined the effect of guided narrative technique (GNT) on child PTSS caused by teachers' improper criticism in school settings.

02

Conditions studied

  • Posttraumatic Stress Symptoms

Keywords

  • Children
  • Teachers' Improper Criticism
  • Posttraumatic Stress Symptoms
  • Expressive Writing
  • Psychological Intervention
  • Guided Narrative Technique
03

In context

Lead sponsor

Peking University is the lead sponsor of 411 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 5th grade students
  • 7-13 years old
  • with the ability to read and write

Exclusion criteria

Exclusion Criteria:

  • younger than 7 years old or older than 13 years old
  • having psychotic disorders
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Treatment group

    Behavioral: guided narrative technique-writing

  • No intervention
    Control group

Interventions

  • Behavioralguided narrative technique-writing

    The experimental group underwent the psychological intervention of guided narrative technique-writing with the theme of teacher criticism for 20 to 30 minutes once a day for three consecutive days.

06

What researchers measure

Primary outcomes

  1. change from baseline child posttraumatic stress symptoms at posttreatment

    Foa et al.,(2018) revised the Self-Rating Scale for Symptoms of Post-traumatic Stress Disorder in Children (CPSS-5-SR), with Cronbach's α reliability coefficient of 0.78. Cpss-5-SR is a 27-item self-reporting measure. Symptom items were scored on a 5-point scale, ranging from 0 (not at all) to 4 (almost always).

    Time frame: 1 week

  2. change from baseline child posttraumatic stress symptoms at follow-up

    Foa et al.,(2018) revised the Self-Rating Scale for Symptoms of Post-traumatic Stress Disorder in Children (CPSS-5-SR), with Cronbach's α reliability coefficient of 0.78. Cpss-5-SR is a 27-item self-reporting measure. Symptom items were scored on a 5-point scale, ranging from 0 (not at all) to 4 (almost always).

    Time frame: 6 months

07

Study locations

1 site
  • Peking University
    Beijing, Beijing, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05416671
Lead sponsor
Peking University
Responsible party
YinyinZang (Principal Investigator, Peking University) — Principal investigator
First posted
Jun 13, 2022
Start date
May 1, 2020
Primary completion
Dec 1, 2020
Completion
Jun 1, 2021
Last update
Jun 13, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion